OpenFDA

OpenFDA Provides Greater Insight Into Drug Injuries and Defective Medical Devices

by Staff Blogger | September 2nd, 2014

Each year, hundreds of thousands of patients become drug injury victims or are harmed by defective medical devices. Most experts agree that more transparency within the medical field is one of the best ways to reduce the number of adverse health events patients suffer due to negligence or error. This is why the U.S. Food and Drug Administration (FDA) has launched a new database known as OpenFDA.

Officials say the database, which currently holds more than 3 million documents, gives the public access to reports and records regarding incidents of patient harm. While OpenFDA is still in it’s testing phase, many believe the information provided will lead to faster action being taken when problems with specific medical products are identified.

The new system will also create a more efficient means for data to be analyzed by researchers, providing a greater insight into focused areas of medicine.

At Ferrer, Poirot & Wansbrough, our drug injury attorneys are excited about the FDA’s new system and are hopeful that it’s successful in providing a greater scope of information about the medical industry to the American people.

OpenFDA Now Includes Information About Recalled Products

by Staff Blogger | July 22nd, 2014

The U.S Food and Drug Administration (FDA) recently launched a database to create better access to the agency’s plethora of data. Now, the FDA has stated they have expanded the system to include vital information about faulty products, such as defective medical devices and dangerous medications.

According to a press release from iHealthBeat, the OpenFDA system will now feature several million reports on product recalls and their related adverse health events. The hope of adding these files is to improve transparency of the data collected by the federal government to improve manufacturer accountability and reduce the number of injuries, illnesses, and deaths caused by faulty products.

So far, the OpenFDA is being hailed as a success and has already been accessed by as many as 18,000 mobile devices with more than 2.4 million API calls.

The new system has also sparked engagement with the public, spawning a new website dedicated to answering questions regarding defective products that are recalled.

The drug injury attorneys with Ferrer, Poirot & Wansbrough are aware of the importance of the public having access to information about recalled products and are excited to see this new system give Americans the ability to retrieve such data at the touch of a button.